Roche announces hub for cardiovascular, renal and metabolism research
CVRM product development global head and senior vice-president Manu Chakravarthy will be the centre's site head.
Fierce Pharma1h
GSK, Novartis, Lilly among Big Pharmas celebrating International Women’s Day 2025
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
Banker & Tradesman2h
Harvard’s Allston Development Lands First Tenant
The first life science tenant at Harvard’s new Allston development is a research center that could eventually become home to ...
Business Journal Daily7h
Women Raise Awareness About Menopause Symptoms and Work
Some women in senior leadership positions leave their jobs or reduce their hours as a result of debilitating side effects ...
The Harvard Crimson11h
Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...
Biontech Announces Fourth Quarter And Full Year 2024 Financial Results And Corporate Update
Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan- ...
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Roche Holding AG (OtherRHHVF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Protagonist Therapeutics (PTGX – Research Report) and Roche ...
Optometry Advisor2h
FDA Approves TNKase for Acute Ischemic Stroke
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.